XML 23 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Revision of Prior Period, Accounting Standards Update, Adjustment
Ordinary shares
Additional Paid-in Capital
Additional Paid-in Capital
Revision of Prior Period, Accounting Standards Update, Adjustment
Retained Earnings
Retained Earnings
Revision of Prior Period, Accounting Standards Update, Adjustment
Treasury Shares
Accumulated Other Comprehensive Income (Loss)
Total SGH Shareholders’ Equity
Total SGH Shareholders’ Equity
Revision of Prior Period, Accounting Standards Update, Adjustment
Non- controlling Interest in Subsidiary
Common stock, beginning balance (in shares) at Aug. 27, 2021     50,138                  
Beginning balance at Aug. 27, 2021 $ 318,924   $ 1,504 $ 396,120   $ 184,787   $ (50,545) $ (221,615) $ 310,251   $ 8,673
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income (loss) 20,698         20,027       20,027   671
Other comprehensive income (loss) (19,440)               (19,440) (19,440)    
Shares issued under equity plans (in shares)     734                  
Shares issued under equity plans 5,029   $ 22 5,007           5,029    
Repurchase of ordinary shares (in shares)     (51)                  
Repurchase of ordinary shares (2,666)   $ (2) 2       (2,666)   (2,666)    
Share-based compensation expense 9,739     9,739           9,739    
Common stock, ending balance (in shares) at Nov. 26, 2021     50,821                  
Ending balance at Nov. 26, 2021 332,284   $ 1,524 410,868   204,814   (53,211) (241,055) 322,940   9,344
Common stock, beginning balance (in shares) at Aug. 27, 2021     50,138                  
Beginning balance at Aug. 27, 2021 318,924   $ 1,504 396,120   184,787   (50,545) (221,615) 310,251   8,673
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income (loss) 48,165                      
Common stock, ending balance (in shares) at May. 27, 2022     52,432                  
Ending balance at May. 27, 2022 399,069   $ 1,573 437,863   231,385   (67,345) (210,874) 392,602   6,467
Common stock, beginning balance (in shares) at Aug. 27, 2021     50,138                  
Beginning balance at Aug. 27, 2021 $ 318,924   $ 1,504 396,120   184,787   (50,545) (221,615) 310,251   8,673
Common stock, ending balance (in shares) at Aug. 26, 2022 48,604   52,880                  
Ending balance at Aug. 26, 2022 $ 378,546 $ (32,183) $ 1,586 448,112 $ (50,822) 251,344 $ 18,639 (107,776) (221,655) 371,611 $ (32,183) 6,935
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06                      
Common stock, beginning balance (in shares) at Nov. 26, 2021     50,821                  
Beginning balance at Nov. 26, 2021 $ 332,284   $ 1,524 410,868   204,814   (53,211) (241,055) 322,940   9,344
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income (loss) 2,972         2,458       2,458   514
Other comprehensive income (loss) 11,379               11,379 11,379    
Shares issued under equity plans (in shares)     372                  
Shares issued under equity plans 2,431   $ 11 2,420           2,431    
Repurchase of ordinary shares (in shares)     (4)                  
Repurchase of ordinary shares (229)             (229)   (229)    
Share-based compensation expense 9,848     9,848           9,848    
Distribution to noncontrolling interest (3,773)                     (3,773)
Common stock, ending balance (in shares) at Feb. 25, 2022     51,189                  
Ending balance at Feb. 25, 2022 354,912   $ 1,535 423,136   207,272   (53,440) (229,676) 348,827   6,085
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income (loss) 24,495         24,113       24,113   382
Other comprehensive income (loss) 18,802               18,802 18,802    
Shares issued under equity plans (in shares)     1,243                  
Shares issued under equity plans 4,389   $ 38 4,351           4,389    
Repurchase of ordinary shares (13,905)             (13,905)   (13,905)    
Share-based compensation expense 10,376     10,376           10,376    
Common stock, ending balance (in shares) at May. 27, 2022     52,432                  
Ending balance at May. 27, 2022 $ 399,069   $ 1,573 437,863   231,385   (67,345) (210,874) 392,602   6,467
Common stock, beginning balance (in shares) at Aug. 26, 2022 48,604   52,880                  
Beginning balance at Aug. 26, 2022 $ 378,546 (32,183) $ 1,586 448,112 (50,822) 251,344 18,639 (107,776) (221,655) 371,611 (32,183) 6,935
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income (loss) 5,324         4,992       4,992   332
Other comprehensive income (loss) (1,995)               (1,995) (1,995)    
Shares issued under equity plans (in shares)     1,060                  
Shares issued under equity plans 3,942   $ 32 3,910           3,942    
Repurchase of ordinary shares (4,659)             (4,659)   (4,659)    
Share-based compensation expense 10,412     10,412           10,412    
Common stock, ending balance (in shares) at Nov. 25, 2022     53,940                  
Ending balance at Nov. 25, 2022 $ 359,387   $ 1,618 411,612   274,975   (112,435) (223,650) 352,120   7,267
Common stock, beginning balance (in shares) at Aug. 26, 2022 48,604   52,880                  
Beginning balance at Aug. 26, 2022 $ 378,546 $ (32,183) $ 1,586 448,112 $ (50,822) 251,344 $ 18,639 (107,776) (221,655) 371,611 $ (32,183) 6,935
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income (loss) $ (45,539)                      
Common stock, ending balance (in shares) at May. 26, 2023 49,807   55,159                  
Ending balance at May. 26, 2023 $ 324,166   $ 1,655 432,185   223,301   (124,659) (214,385) 318,097   6,069
Common stock, beginning balance (in shares) at Nov. 25, 2022     53,940                  
Beginning balance at Nov. 25, 2022 359,387   $ 1,618 411,612   274,975   (112,435) (223,650) 352,120   7,267
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income (loss) (26,786)         (27,219)       (27,219)   433
Other comprehensive income (loss) 6,093               6,093 6,093    
Shares issued under equity plans (in shares)     443                  
Shares issued under equity plans 308   $ 13 295           308    
Repurchase of ordinary shares (11,564)             (11,564)   (11,564)    
Share-based compensation expense 10,395     10,395           10,395    
Purchase of Capped Calls (15,090)     (15,090)           (15,090)    
Settlement of Capped Calls 10,786     10,786           10,786    
Distribution to noncontrolling interest (2,009)                     (2,009)
Common stock, ending balance (in shares) at Feb. 24, 2023     54,383                  
Ending balance at Feb. 24, 2023 331,520   $ 1,631 417,998   247,756   (123,999) (217,557) 325,829   5,691
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income (loss) (24,077)         (24,455)       (24,455)   378
Other comprehensive income (loss) 3,172               3,172 3,172    
Shares issued under equity plans (in shares)     776                  
Shares issued under equity plans 4,180   $ 24 4,156           4,180    
Repurchase of ordinary shares (660)             (660)   (660)    
Share-based compensation expense $ 10,031     10,031           10,031    
Common stock, ending balance (in shares) at May. 26, 2023 49,807   55,159                  
Ending balance at May. 26, 2023 $ 324,166   $ 1,655 $ 432,185   $ 223,301   $ (124,659) $ (214,385) $ 318,097   $ 6,069